Science meets digital networking: for efficient production
Innovative pharmaceutical products are there to help people. A digitalized manufacturing process fosters efficient and secure production. That’s inmation. Our platform ensures that production data reaches the respective decision makers in real time. For scientific progress that drives economic success.
In the spotlight: how we help customers in the Pharmaceutical industry
Explore how system:inmation based projects drive digital transformation in leading Pharmaceutical companies:
Bayer Consumer Health
Digital@CHPS is the name of the digitalization offensive launched at Bayer Consumer Health in February 2018. The name of the corresponding software in use at their production sites worldwide: enterprise:inmation. Connected to the majority of production and packaging lines, the system unifies disparate data in one system. Whether machines, automation systems, or manufacturing execution – all components of each production units are mapped.
“... an orchestra stage including the conductor.”

-
About Bayer Consumer Health
Bayer Consumer Health is a global life sciences company focused on health and nutrition. Bayer's products and services help people meet the challenges of a growing and aging world population. The company strives for sustainable development and stands for trust, reliability, and quality.
-
What we achieved
-
Increased efficiency in the production process: resulting in less waste and fewer breakdowns.
-
Complete data set is captured, contextualized, and aggregated – and exposed to all users in short order.
-
The global roll-out of Digital@CHPS – only possible thanks to the cooperation of inmation and its network of partners.
-
-
What lies ahead
Bayer Consumer Health is now a member of inmation's Product Advisory Board. This enables even closer cooperation with our partners: together we are expanding the roll-out of Digital@CHPS.
Boehringer Ingelheim
Connecting more than 40 PLCs – that's only where we started with enterprise:inmation at Boehringer Ingelheim. After a short pilot phase, the human pharma division started a global roll-out of our platform. Launched under the name "Smart Manufacturing", our software facilitates improving efficiency at all research and production sites worldwide.
“enterprise:inmation is a great way to further advance the digital integration of our pharmaceutical production lines, to reduce costs and make our systems fit for the future. Boehringer Ingelheim and inmation are two global leaders based in Germany – this is the beginning of a perfect partnership.”

-
About Boehringer Ingelheimer
Boehringer Ingelheimer is one of the top 20 companies in the pharmaceutical industry with over 50,000 employees at sites around the world. Based in Germany, the group has been family-owned since its founding in 1885. With one important focus: conducting research for products that can improve patients' lives.
-
What we achieved
-
Successful digital linking between the various production lines while reducing costs at the same time.
-
Central control via a DevOps Center in Spain: close collaboration with Boehringer Ingelheim's IT team.
-
Boehringer Ingelheim has been a member of inmation's Product Advisory Board since December 2017.
-
-
What lies ahead
inmation and Boehringer Ingelheimer are committed to our long-term partnership. That’s why we keep developing our software further in alignment with the GxP requirements for pharmaceutical production.
One software, many possibilities
Our solution can be flexibly adapted to the individual needs of your business – and it's also modularly scalable after implementation. That's why customers from many different industries choose us:









Free consultation: Talk with us about your company's needs
Are you ready to unleash our software in your business? Get in touch with us today to arrange a consultation.